πŸͺ The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
Forumsβ€ΊPublic Squareβ€ΊSemaglutide and gallbladder disease risk β€” my results so far β€Ί Page 5

Semaglutide and gallbladder disease risk β€” my results so far

lisa_labSD Wed, Jun 4, 2025 at 10:48 PM 44 replies 2,339 viewsPage 5 of 9
tampaLisa73
Member
312
1,456
Oct 2024
Tampa, FL
Jun 5, 2025 at 5:53 AM#21

Congrats lisa_labSD!! Keep going β€” you're doing incredible. πŸŽ‰

4 20RunnerRach, TrialNerd_Beth, HPLC_Greg and 1 other
Reply Quote Save Share Report
DerekSJ_a1c
Member
378
1,678
Aug 2024
San Jose, CA
Jun 5, 2025 at 6:10 AM#22

Reading this thread on Semaglutide and hits close to home. Night shift nurse β€” I started at 283 lbs and felt like I would tried everything.

9 months on tirz and I am a different person. Not just the 58 lbs lost β€” my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Semaglutide and β€” take the leap. It was the best health decision I have ever made. ❀️

4 23Dr.SurgeonPGH, rachel_ABQ, traveltech_sara and 1 other
Reply Quote Save Share Report
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Jun 5, 2025 at 6:27 AM#23

As a pharmacist, I want to add some clinical context to this discussion on Semaglutide and gallbladder disease risk.

Building on what tampaLisa73 said β€” the evidence base here is robust. The key publications to reference are from the FLOW program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
41 8tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 38 others
Reply Quote Save Share Report
gary_naperville
Member
245
1,123
Oct 2024
Naperville, IL
Jun 5, 2025 at 6:44 AM#24

DerekSJ_a1c β€” wow. I've been looking for this exact info for weeks.

Last edited: Jun 5, 2025 at 9:44 AM
29 7PharmHunterJen, TomTeleRx, DoseLogDan and 26 others
Reply Quote Save Share Report
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Jun 5, 2025 at 7:01 AM#25

Adding my data to this Semaglutide and discussion:

MetricBaselineMonth 5Month 6
Weight276 lbs231 lbs221 lbs
A1C7.0%6.0%5.2%
hsCRP5.04.01.0

Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.3g/kg/day.

38 12SaraMom3, Dr.MetabolicMD, RetaRick_CA and 35 others
Reply Quote Save Share Report
1…34567…9

Similar Threads

SELECT trial 4-year follow-up data released β€” sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns β€” evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey β€” comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register